Protein Supplementation and HIIT: Impact on Cardiorespiratory Fitness
NCT ID: NCT04359342
Last Updated: 2020-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2020-01-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Whey Protein Support to Metabolic and Performance Adaptations in Response HIIT
NCT03570424
Impact of Protein Supplementation and Resistance Training on Body Composition, Functional Parameters, Metabolic Adaptation, and Nitrogen Balance in Adults Aged 45 Years and Older With Overweight or Obesity Receiving Incretin-based Medications
NCT06950684
Essential Amino Acids and High Intensity Interval Training
NCT04080102
Resistance and Aerobic Exercise With Nutritional Supplementation in Men and Women
NCT00812409
Effects of High Protein Intake With Intense Exercise and Energy Deficit
NCT01776359
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HIIT + protein
High-intensity interval training (HIIT) combined with protein supplementation
HIIT + protein
8-week supervised exercise program consisting of high-intensity interval training (HIIT).
HIIT: 10x1 min at 85-95% HRmax divided by low intensity recovery periods. Three exercise sessions per week. Participants receive 40 g of a commercially available protein supplement administered as a shake after every exercise session.
HIIT + placebo
High-intensity interval training (HIIT) combined with placebo
HIIT + placebo
8-week supervised exercise program consisting of high-intensity interval training (HIIT).
HIIT: 10x1 min at 85-95% HRmax divided by low intensity recovery periods. Three exercise sessions per week. Participants receive 40 g of a commercially available iso-caloric placebo (Maltodextrin) administered as a shake after every exercise session.
HIIT and resistance training + protein
High-intensity interval training (HIIT) and resistance training combined with protein supplementation
HIIT and resistance training + protein
8-week supervised exercise program consisting of high-intensity interval training (HIIT) and resistance training (RST).
HIIT: 5x1 min at 85-95% HRmax divided by low intensity recovery periods. RST: 3-set resistance training using weight machines to train all major muscle groups with an individual intensity corresponding to 70-80% of one repetition maximum. Two exercise sessions per week. Participants receive 40 g of a commercially available protein supplement administered as a shake after every exercise session.
HIIT and resistance training + placebo
High-intensity interval training (HIIT) and resistance training combined with placebo
HIIT and resistance training + placebo
8-week supervised exercise program consisting of high-intensity interval training (HIIT) and resistance training (RST).
HIIT: 5x1 min at 85-95% HRmax divided by low intensity recovery periods. RST: 3-set resistance training using weight machines to train all major muscle groups with an individual intensity corresponding to 70-80% of one repetition maximum. Two exercise sessions per week. Participants receive 40 g of a commercially available iso-caloric placebo (Maltodextrin) administered as a shake after every exercise session.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HIIT + protein
8-week supervised exercise program consisting of high-intensity interval training (HIIT).
HIIT: 10x1 min at 85-95% HRmax divided by low intensity recovery periods. Three exercise sessions per week. Participants receive 40 g of a commercially available protein supplement administered as a shake after every exercise session.
HIIT + placebo
8-week supervised exercise program consisting of high-intensity interval training (HIIT).
HIIT: 10x1 min at 85-95% HRmax divided by low intensity recovery periods. Three exercise sessions per week. Participants receive 40 g of a commercially available iso-caloric placebo (Maltodextrin) administered as a shake after every exercise session.
HIIT and resistance training + protein
8-week supervised exercise program consisting of high-intensity interval training (HIIT) and resistance training (RST).
HIIT: 5x1 min at 85-95% HRmax divided by low intensity recovery periods. RST: 3-set resistance training using weight machines to train all major muscle groups with an individual intensity corresponding to 70-80% of one repetition maximum. Two exercise sessions per week. Participants receive 40 g of a commercially available protein supplement administered as a shake after every exercise session.
HIIT and resistance training + placebo
8-week supervised exercise program consisting of high-intensity interval training (HIIT) and resistance training (RST).
HIIT: 5x1 min at 85-95% HRmax divided by low intensity recovery periods. RST: 3-set resistance training using weight machines to train all major muscle groups with an individual intensity corresponding to 70-80% of one repetition maximum. Two exercise sessions per week. Participants receive 40 g of a commercially available iso-caloric placebo (Maltodextrin) administered as a shake after every exercise session.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Psychological disorders, epilepsy, sever neurological disorders
* Participation in other exercise- or nutrition studies within the last 6 months
* coronary heart disease, heart failure
* malignant disease
* severe rheumatic or neurological disease
* severe/unstable hypertension (resting RR: \>180/\>110 mmHg)
* severely restricted lung function (FEV1 \<60%)
* unstable Diabetes mellitus
* severe orthopedic disease/restriction
* acute / chronic infectious diseases
* Electronic implants (defibrillator, pacemaker)
* Persons in mental hospitals by order of authorities or jurisdiction
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Erlangen-Nürnberg Medical School
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dejan Reljic, Dr.
Role: PRINCIPAL_INVESTIGATOR
University Erlangen Nuremberg Medical School
Yurdagül Zopf, Prof.
Role: PRINCIPAL_INVESTIGATOR
University Erlangen Nuremberg Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports, Friedrich-Alexander-University Erlangen-Nuremberg
Erlangen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRO-HIIT Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.